Beryl Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

26.73

26.89

14.60

14.09

13.05

Operating profit

2.28

1.95

0.41

1.45

1.14

Interest

0.46

0.42

0.44

0.47

0.32

Gross profit

2.21

1.80

0.14

1.17

0.82

EPS (Rs)

1.52

1.51

-1.30

0.47

0.09

Other income

0.40

0.27

0.16

0.19

-

Stock adjustment

-0.17

0.31

-0.30

-0.03

-0.07

Raw material

13.31

14.23

8.71

7.45

6.68

Power and fuel

-

-

-

-

-

Employee expenses

1.93

1.70

1.31

1.18

0.97

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

9.38

8.71

4.48

4.05

4.34

Provisions made

-

-

-

-

-

Depreciation

1.20

0.81

1.09

1.27

0.66

Taxation

0.24

0.22

-0.29

0.11

0.11

Net profit / loss

0.77

0.77

-0.66

0.24

0.05

Extra ordinary item

-

-

-

0.45

-

Prior year adjustments

-

-

-

-

-

Equity capital

5.07

5.07

5.07

5.07

5.07

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

8.53

7.23

2.79

10.28

8.72

GPM (%)

8.15

6.62

.92

8.19

-

NPM (%)

2.83

2.82

-4.46

1.68

-